1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Penicillin and Streptomycin Market Research and Forecast 2017-2022

Global Penicillin and Streptomycin Market Research and Forecast 2017-2022

  • March 2017
  • 120 pages
  • ID: 5336639

Summary

Table of Contents

The global Penicillin and Streptomycin market is estimated to grow at a CAGR of 0.5% from 2017-2022. Penicillin and streptomycin are two of the most widely prescribed antibiotics globally.

These antibiotics are capable of preventing bacterial growth. According to a recent report by Orion Market Research, various factors responsible for market growth include increasing number of contagious diseases and heavy investments in research and development. Increasing demand for generic drugs is also adding to the market growth.

The Penicillin and Streptomycin market has growth opportunities with innovations in new product development and usage of penicillin-streptomycin compound in cell culture as anti-bacterial agent.

However, government regulations and patent expiry issues are major challenges to the growth of the market. Increasing incidences of anti-microbial resistance are also impeding the growth of the market New antibiotics have been developed and used with lesser side effects compared to penicillin and streptomycin which has affected the market of penicillin and streptomycin.

The market is segmented on the basis of product type (bulk and dosage), manufacturing process (synthetic process, natural process, semi-synthetic process and natural process) and route of administration (oral, intravenous and intramuscular). The end users include hospitals, clinics and others.

GEOGRAPHICAL INSIGHTS
Geographically, Asia Pacific holds the maximum of market share is expected to be the largest market for penicillin and streptomycin drugs during the forecasted period. The market is majorly driven by high level of infections due to lack of proper infrastructure and cleanliness.

The market is also dominated by some of the world’s largest generic drug manufacturers which are also dominating the penicillin and streptomycin production. The market is then dominated by North American region and Europe. These market are highly developed with high level of awareness regarding infectious diseases caused by bacteria, proper healthcare infrastructure and government regulations.

The report includes detailed market overview, market determinants, company profiling, market segmentation, geographical analysis, patent analysis, strategic recommendations, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.

Competitive Insights
Major players in the market include Abbot Laboratories, Bristol Myers Squibb Co., Johnson & Johnson, Pfizer, Amgen, Biogen Idec, Celgine Corporation, Merck & Co., Inc., Gilead Sciences Inc., Eli Lilly and Co, Astra Zeneca, Sanofi Aventis SA, GlaxoSmithKline Plc, Roche Pharmaceuticals, Novartis AG, Bayer HealthCare AG, Toyama Chemical Co., Ltd, Astellas Pharma Inc., MiddleBrook Pharmaceuticals and Takeda Pharmaceutical Company.

MARKET SEGMENTATION
o Penicillin and streptomycin market by product
- penicillin
• Penicillin by bulk
• Penicillin by dosage
- Streptomycin
• Streptomycin by bulk
• Streptomycin by dosage

o Penicillin and streptomycin market by manufacturing process
o Penicillin and streptomycin market by route of administration
o Penicillin and streptomycin market by end users market

THE REPORT COVERS
• Comprehensive research methodology of Global Penicillin and Streptomycin Market.
• This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst’s insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global Penicillin and Streptomycin Market.
• Insights about market determinants which are stimulating the Global Penicillin and Streptomycin Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Clinical Research in Typhoid Fever in H2, 2018

Clinical Research in Typhoid Fever in H2, 2018

  • $ 2500
  • September 2018

Typhoid Fever Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Typhoid Fever Global Clinical Trials Review, H2, 2018" provides an overview of Typhoid Fever clinical ...

2018 US Clinical Chemistry and Immunodiagnostic Analyzers, Reagents and over 100 Tests--Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

2018 US Clinical Chemistry and Immunodiagnostic Analyzers, Reagents and over 100 Tests--Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 4200
  • September 2018

VPGMarketResearch.com’s new report is a strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the next five years. The report explores ...

Clinical Research in Trichuriasis in H2, 2018

Clinical Research in Trichuriasis in H2, 2018

  • $ 2500
  • September 2018

Trichuriasis Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Trichuriasis Global Clinical Trials Review, H2, 2018" provides an overview of Trichuriasis clinical trials ...


ref:plp2017

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on